Abstract:Objective: Preeclampsia (PE) is a significant cause of maternal and offspring mortality and morbidity. The purpose of this study is to identify the potential diagnostic signatures of autophagy-related genes (ATGs) in pregnancies with preeclampsia. Methods: The expression profile of mRNA was obtained from GSE75010 (placenta samples) and GSE48424 dataset (blood samples). The potential differentially expressed ATGs of PE were screened by R software. The gene-ontology (GO) enrichment analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis, correlation analysis, and protein-protein interactions (PPI) were applied for the differentially expressed ATGs. The diagnostic markers of PE were then screened based on least absolute shrinkage and selection operator (LASSO) logistic regression and support vector machine-recursive feature elimination (SVM-RFE). Receiver operating characteristic (ROC) analysis was used to investigate the predictive value of these diagnostic markers. Target miRNAs were predicted based on the miRDB, DIANA-micro T, Targetscan, and miRWalk databases, and were further validated in GSE84260. Results: A total of 20 differentially expressed ATGs were identified between PE and healthy pregnancies. Functional analysis of differentially expressed ATGs indicated several enriched terms related to autophagy, apoptosis, angiogenesis, inflammation, immune response, hypoxia-inducible factor 1 (HIF-1), forkhead box O (FoxO) and AMP-activated protein kinase (AMPK) signaling pathway. A total of 12 ATGs were recognized based on LASSO and SVM-RFE, which made an excellent distinction in both the placenta tissues (area under the curve [AUC] = 0.903) and the blood samples (AUC = 0.972). Furthermore, four feature ATGs (leptin [LEP], ERO1-like [ERO1L], phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [PIK3CB], and mitogen-activated protein kinase 8 [MAPK8]) were screened and also shown an excellent diagnostic efficacy (AUC = 0.869 in placenta samples, and AUC = 0.914 in blood samples). Additionally, 81 target miRNAs were predicted according to the 4 feature ATGs. After evaluating the miRNA expression pattern of GSE84260, 11 miRNAs were selected. Finally, a miRNA-mRNA regulatory network was constructed, which may participate in the development of PE. Conclusions: We established an autophagy-related-gene based signature that may predict pregnancies with PE. And we also constructed a miRNA-mRNA regulatory network, which may deepen our understanding of the molecular mechanism underlying the development of PE.

Identification of differentially expressed miRNAs in plasma exosomes from patients with early-onset pre-eclampsia using next generation sequencing

High Throughput Sequencing Analysis of Exosomal miRNA Expressions in Early-Onset Preeclampsia Patients

Bioinformatics-based Identification of Mirna-, Lncrna-, and Mrna-Associated Cerna Networks and Potential Biomarkers for Preeclampsia.

Deregulated microRNA species in the plasma and placenta of patients with preeclampsia.

Profiling of Exosomal Micrornas Expression in Umbilical Cord Blood from Normal and Preeclampsia Patients

Maternal Plasma Mirnas Expression in Preeclamptic Pregnancies

Differential Expression Of Micrornas In The Placentae Of Chinese Patients With Severe Pre-Eclampsia

Pathogenic Mechanisms of Preeclampsia with Severe Features Implied by the Plasma Exosomal Mirna Profile

Integrated analysis of microRNA and mRNA expression profiles in Preeclampsia

Application of Next-Generation Sequencing Technology to Profile the Circulating Micrornas in the Serum of Preeclampsia Versus Normal Pregnant Women

Small RNA sequencing reveals placenta-derived exosomal microRNAs associated with preeclampsia

Placenta-derived exosomes as carriers of non-coding RNAs in maternal circulation of patients with preeclampsia

Study on the differential expression of microRNAs in the preeclampsia serum

Circulating extracellular vesicular microRNA signatures in early gestation show an association with subsequent clinical features of pre-eclampsia

MiR-210 and Mir-155 As Potential Diagnostic Markers for Pre-Eclampsia Pregnancies

A Potential Autophagy-Related-Gene Based Signature in Patients with Preeclampsia

miR-31-5p from placental and peripheral blood exosomes is a potential biomarker to diagnose preeclampsia

Exosomal small RNA profiling in first-trimester maternal blood explores early molecular pathways of preterm preeclampsia

A cross-sectional analysis of syncytiotrophoblast membrane extracellular vesicles-derived transcriptomic biomarkers in early-onset preeclampsia

Identification of mRNA-, circRNA- and lncRNA- Associated ceRNA Networks and Potential Biomarkers for Preeclampsia From Umbilical Vein Endothelial Cells

The aberrantly expressed miR-193b-3p contributes to preeclampsia through regulating transforming growth factor-β signaling